Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04996251 · ClinicalTrials.gov registry record · Phase 4
Pre-incision Versus Post-incision Local Anesthetic During Robotic Sacrocolpopexy
A Phase 4 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 129
- Enrollment target
NCT04996251 is a Phase 4 study that has completed, run by Northwell Health. The registered enrollment target is 129 participants.
The verdict
NCT04996251, a Phase 4 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 129 participants
- Enrollment target
Study Summary
Obtaining Likest-pain scale score on postoperative day one after injection of local anesthetic into incision sites of a laparoscopic/robotic-assisted sacrocolpopexy
Interventions
- DRUG Bupivacaine Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2021-07-30 |
| Est. Completion | 2023-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04996251
The ClinicalTrials.gov registry entry for NCT04996251 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bupivacaine Injection is the first listed.
NCT04996251 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04996251 about?
NCT04996251 is a clinical study titled "Pre-incision Versus Post-incision Local Anesthetic During Robotic Sacrocolpopexy". Obtaining Likest-pain scale score on postoperative day one after injection of local anesthetic into incision sites of a laparoscopic/robotic-assisted sacrocolpopexy
What is the current status of trial NCT04996251?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 129 participants. The study started on 2021-07-30. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT04996251?
The interventions under investigation include: Bupivacaine Injection (DRUG).
Who is sponsoring clinical trial NCT04996251?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.